High myopia following unilateral cryocoagulation for threshold retinopathy of prematurity by Omar, Nazri et al.
Malaysian Journal of Medicine and Health Sciences Vol 12 (2) June 2016
Malaysian Journal of Medicine and Health Sciences (ISSN 1675-8544); Vol 12 (2) June 2016
ABSTRACT
Despite the proven benefit of cryotherapy in the management of
threshold retinopathy of prematurity (ROP), it was shown
leading to ocular adverse effects. A male infant was born at 28
week of gestation with a birth weight of 1200 g. Serial
examinations revealed worsening ROP in both eyes until he
reached a high risk pre-threshold ROP in his right eye and
threshold ROP in his left eye. Cryotherapy was performed for
the threshold ROP in the left eye while the right eye was
subjected to further observation. Subsequently, ROP in both
eyes regressed without cicatrisation. The patient was followed-
up over 8 years and refractions showed that the treated eye
developed steadily increasing myopia while the untreated eye
remained emmetropic. This case demonstrated the detrimental
effect of cryotherapy to the treated eye leading to the progressive
myopia as the child grew.  
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prematurity
INTRODUCTION
Treatment is indicated in threshold retinopathy of prematurity
(ROP) to prevent unfavourable visual outcomes. The CRYO-
ROP study paved way for evidence-based treatment of ROP by
peripheral retinal ablation using cryocoagulation. Cryotherapy
was shown to be an effective treatment in threshold ROP before
the introduction of laser therapy. However, cryotherapy can lead
to ocular and systemic adverse effects. This report highlights the
adverse effect of cryotherapy in threshold ROP.
CASE REPORT
A male infant was born at 28 week of gestation with a birth
weight of 1200 g. Patient was intubated for three days followed
by nasal continuous positive airway pressure (NCPAP)
treatment for two weeks. He also had multiple conditions such as
respiratory distress syndrome, anaemia of prematurity and
G6PD deficiency. 
He progressed to high risk pre-threshold ROP in his right eye
and threshold ROP in his left eye. Treatment was decided upon
but the laser was unfortunately unavailable at that time.
Cryotherapy was performed for the threshold ROP in the left
eye. The pre-threshold ROP in the right eye was subjected to
further observation. Subsequently, ROP in both eyes regressed
without cicatrisation. 
The patient was followed up regularly over 8 years and serial
refractions showed that the treated eye developed steadily
increasing myopia while the untreated eye remained
emmetropic. Latest refraction showed emmetropic right eye but
the left eye had -10.00 DS/-3.00 DC x170 (Fig. 1). Fundus
examination revealed normal right eye and tigroid left eye with
tilted optic disc indicating elongated globe (Fig. 2). A-scan
biometry revealed an axial length of 22.81 mm ± 0.02 mm (mean
± standard deviation, SD) in the right eye and 26.30 mm ± 0.01
mm (mean ± SD) in the left eye. Other parameters of the eyes are
shown in Table 1. At latest review, the patient was prescribed
with full correction spectacle which he tolerated well with best
corrected visual acuity of 6/6 and 6/7.5 in the right and left eyes,
respectively (Fig. 3).
DISCUSSION
The primary goal of the CRYO-ROP study was to investigate the
efficacy of peripheral retinal ablation procedure for treatment for
ROP, of which cryotherapy was most widely used at that time.
Initial publications from the study clearly demonstrated a
statistically and clinically relevant 49.3% reduction in the rate of
unfavourable outcome in the treated eyes when compared with
the control eyes (1). At about the same time of the trial,
transpupillary laser photocoagulation was introduced as an
alternative treatment. Subsequently, the wide availability of
portable lasers with indirect ophthalmoscopic delivery, which
can be applied transpupillary with fewer associated local and
systemic adverse effects such as pain and swelling, allowed laser
photocoagulation to become the most widely used treatment for
ROP. Laser photocoagulation remained as the predominant
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Figure 1: Line chart showing the refractive changes in the patient’s right and left eyes (D, dioptre; R sp, Right eye, spherical;
R cyl, Right eye, cylindrical; L sp, Left eye, spherical; L cyl, Left eye, cylindrical).
Figure 2: Photographs showing normal right eye (A) and markedly tigroid fundus in the left eye with no scarring from
retinopathy of prematurity in the posterior pole (B).
Table 1: Biometric comparison between the patient’s untreated right eye and cryo-treated left eye. 
Right eye Left eye
K, vertical, D 45.00 46.00
K, horizontal, D 44.75 44.50
Corneal astigmatism, D 0.25 1.50
Axial length, mm 22.81 ± 0.02 26.30 ± 0.01
Anterior chamber depth, mm 3.91 ± 0.05 3.50 ± 0.04
Lens thickness, mm 3.30 ± 0.05 3.57 ± 0.05
Vitreous length, mm 15.61 ± 0.01 19.24 ± 0.02
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method of treatment to the present time, and cryotherapy is
generally reserved for patients with opaque media or other
technical limitations to transpupillary photocoagulation. 
Although there were limited randomized clinical trials directly
comparing cryotherapy and photocoagulation, higher
percentages of poor structural and functional outcomes generally
were seen in eyes treated with cryotherapy compared with eyes
treated with laser treatment. It was shown that the mean
spherical equivalent was significantly higher in the cryotherapy
group than in the laser photocoagulation group (-9.21 D vs. -1.80
D, p = 0.001). Patients in the cryotherapy group were also more
likely to have against-the-rule astigmatism (2). 
Kent et al reported higher axial and posterior segment lengths in
cryo-treated eyes than in untreated or laser-treated eyes.
However, the eyes were not from the same patients (3). In
contrast, Connolly et al observed that laser-treated eyes were
significantly less myopic than cyro-treated eyes predominantly
attributable to the lens power in premature babies with threshold
ROP, after 10 years’ follow up. This finding was accompanied
with shorter axial length and thicker lens in cryo-treated
compared to laser treated eyes (4).
In our report, the cryo-treated eye and the untreated eye were
from the same patient, hence ruling out roles of differences in
genetic, systemic or environmental factors in the development of
the refractive changes. It points to the possibility of a local factor
unique to the treated eye as compared to the fellow eye prior to
the onset of the changes which was the cryotherapy. The patient
also had shallower anterior chamber depth, thicker lens,
increased axial and posterior segment lengths compared to
untreated right eyes (Table 1) which were consistent with
features reported by Kent et al (3). 
In a study of cryo-treated developing eyes in rabbits, Axer-Siegl
et al noted histopathological changes including peripheral
chorioretinal scar, retinal atrophy and microcystoid oedema,
pigment dispersions in the ciliary body without atrophy,
adhesion and condensations of the vitreous, and slight tissue
disorganization of the overlying sclera possibly making it more
susceptible to stretching. These could explain the more severe
myopia in cryo-treated eye compared to laser-treated or
untreated eyes (5). 
Laser photocoagulation is the preferred mode for peripheral
retinal ablation in threshold ROP cases and should be made
available in centres managing ROP. New treatment modality
such as intra-vitreal bevacizumab may offer regression of the
threshold ROP with possibly minimal risk of high refractive
errors.
CONCLUSION 
Although cryotherapy was proven to be effective in reducing the
unfavorable outcome in threshold ROP, it can lead to refractive
side effects such as myopia and astigmatism. Diode laser is
preferred over cryotherapy and should be made available in the
treatment of threshold ROP. 
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Figure 3: Photograph of the patient while using the full-correction spectacles which was well-tolerated despite the
huge anisometropia.
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